Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen
Authors:
- Petra RiedlPRPetra Riedl
- Jörg ReimannJRJörg Reimann
- Reinhold SchirmbeckRSReinhold Schirmbeck
- 1 December 2009
- Vol. 28 (1) , 114-119
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptorNature Medicine, 2008
- Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus InfectionsJournal of Virology, 2008
- Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infectionVirology, 2007
- Confronting Complexity: Real-World Immunodominance in Antiviral CD8+ T Cell ResponsesImmunity, 2006
- All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen‐processing pathwayImmunological Reviews, 2005
- Stealth and Cunning: Hepatitis B and Hepatitis C VirusesJournal of Virology, 2005
- UNDERSTANDING PRESENTATION OF VIRAL ANTIGENS TO CD8+T CELLS IN VIVO: The Key to Rational Vaccine DesignAnnual Review of Immunology, 2005
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variantsEuropean Journal of Immunology, 2003
- Priming polyvalent immunity by DNA vaccines expressing chimeric antigens with a stress protein‐capturing, viral J‐domainThe FASEB Journal, 2002